pharmaphorum

NOVEMBER 15, 2022

The day will continue with other hot topics for pharma, including health equity, cell and gene therapy, oncology, and pharmacy model disruption. Then we’ll hear from Aptar Digital Health’s Sai Shankar and Pierre Laurent in a session all about patients as partners in healthcare.

Gene Therapy 119

Gene Therapy Pharmacy Gene 119

Scienmag

DECEMBER 11, 2020

An international study led by researchers from the Faculty of Pharmacy at the Complutense University of Madrid has identified a series of biosynthetic genes involved in the production of usnic acid in lichen, a compound showing antiviral, antioxidant, neuroprotective, antibacterial and anticancer activity.

Gene 52

Gene Scientist Pharmacy Production 52

pharmaphorum

DECEMBER 2, 2021

As well as being able to make appointments to speak to a doctor, users of the app can also have their prescription sent to a selected pharmacy, check any symptoms of ill-health and manage chronic conditions. The company offers a smartphone application, which can connect patients directly with a healthcare professional.

Genetics 145

Genetics Doctors Doctor Pharmacy 145

pharmaphorum

JANUARY 29, 2021

They studied 56 medicines, including antidepressants, antibiotics, stomach ulcer treatments and painkillers where there are known drug-gene interactions. Essra Youssef, a research pharmacist at UEA’s School of Pharmacy, said: “We know over 95% the population carry a genetic marker that predicts an atypical response to at least one medicine.

Genetics 98

Genetics Pharmacy Medicine Doctors 98

Drug Channels

MAY 9, 2023

Last week, Paula and I had the pleasure of attending Asembia’s 2023 Specialty Pharmacy Summit at the wonderful Wynn Las Vegas. As I do every year, I will violate Vegas code and tell you what happened there.

Pharmacy 98

Pharmacy Marketing Drugs Gene Therapy 98

XTalks

SEPTEMBER 13, 2024

Early this year, Elevance closed its acquisition of Paragon Healthcare, enhancing its specialty pharmacy and infusion services capabilities. Billion Cigna continues to innovate by expanding access to healthcare through its diverse portfolio of insurance, pharmacy benefits management and health services. billion in revenue.

Marketing 98

Marketing Pharmacy Gene Therapy Hormones 98

Pharma Mirror

JULY 23, 2021

SOMERSET, N.J.

Manufacturing 130

Manufacturing Gene Therapy Clinical Development Gene 130

Delveinsight

AUGUST 26, 2021

Shape Therapeutics inks gene therapy deal with Roche worth up to USD 3 Billion. Seattle biotech firm Shape Therapeutics has signed a deal potentially exceeding USD 3 billion with pharma giant Roche to bolster the development of gene therapies for Alzheimer’s and Parkinson’s disease.

Vaccination 98

Vaccination Vaccine Gene Therapy RNA 98

Drug Channels

JUNE 5, 2023

Join peers this August to discover the evolving specialty pharmacy marketplace, build multi-stakeholder partnerships, and explore frameworks to inform your 2024 distribution and patient service strategies.

Pharmacy 74

Pharmacy Gene Therapy Manufacturing Compliance 74

pharmaphorum

JANUARY 11, 2021

Alliance will be able to increase the expansion of its core retail pharmacy business as a result of the transaction, which involves a business that generated revenues of $19 billion in full year 2020. The companies said that the agreement will expand distribution networks for specialty medicines such as cell and gene therapies.

Gene Therapy 84

Gene Therapy Pharmacy Gene Marketing 84

XTalks

NOVEMBER 27, 2024

Syndax Pharmaceuticals’ Revuforj (revumenib) has won US Food and Drug Administration (FDA) approval for the treatment of relapsed or refractory (R/R) acute leukemia in patients aged one year and older who have a lysine methyltransferase 2A ( KMT2A, formerly MLL ) gene translocation.

FDA Approval 99

FDA Approval Drugs Gene Trials 99

Drug Channels

OCTOBER 17, 2022

Don’t miss the chance to unite with colleagues and master the complexities of pharmacy and distribution models to accelerate patient access! View the agenda to see the complete picture – the program, speakers, and more, and visit www.informaconnect.com/trade for further details and to register.

Pharmacy 75

Pharmacy Gene Therapy Drugs Production 75

The Pharma Data

DECEMBER 17, 2020

Doctor Johnson has had an inspiring career that encompasses several aspects of the pharmacy industry. In keeping with her pioneering spirit, she recently expanded into Pharmacogenomics (PGx) gene testing for patients. Doctor Johnson aspires to incorporate the latest technologies available in healthcare to care for her patients.

Medicine 52

Medicine Pharmacy Doctors Doctor 52

XTalks

MARCH 14, 2023

Zavzpret is the first and only calcitonin gene-related peptide (CGRP) receptor antagonist indicated for the treatment of migraines. Zavzpret will be available in pharmacies in July 2023. A migraine is an extremely painful headache that can lead to severe throbbing or pulsing sensations (usually on one side of the head).

FDA Approval 98

FDA Approval Pharmacy Drugs Gene 98

pharmaphorum

AUGUST 10, 2020

for a single shot of the gene therapy, making it the most expensive drug in the world by many people’s reckoning, although the manufacturer argues this is justified given the costs of treating the condition in later life. But Spinraza costs $750,000 in the first year of treatment and about half that price annually from then on.

FDA Approval 59

FDA Approval Drugs Gene Therapy Protein 59

pharmaphorum

JUNE 27, 2022

Jennifer Mathieu, director of government relations at the Academy of Managed Care Pharmacy (AMCP), tells us why the organisation backed the pre-approval information exchange (PIE) Act of 2022 and how the legislation will empower companies to share information with healthcare payers and plans during the FDA approval process. . Jennifer L.

FDA Approval 95

FDA Approval Manufacturing Clinical Trials Clinical Trials 95

Pharmaceutical Technology

APRIL 24, 2023

Conde says the use of nanoparticle delivery for gene therapies has become more common over recent years. Nanoparticles can be tailored to target specific cells or tissues, release gene therapies in a regulated manner, reduce toxicity, and increase stability,” he added.

Drug Delivery 147

Drug Delivery Vaccination Vaccine Research 147

XTalks

AUGUST 30, 2022

We know that a lot of different pathologies, especially as we’ve entered the era of molecular medicine and gene therapies, cause many of the same symptoms and work through final common pathways. Viral Vectors for Gene Delivery to the CNS. Reporter genes to understand dose and distribution. The patients are waiting!

Trials 83

Trials Drug Delivery Drugs Gene 83

Drug Channels

FEBRUARY 6, 2024

Access USA will unite PAP – Patient Assistance & Access Programs, Hub and Specialty Pharmacy Models East and the Rare Disease Summit three influential access conferences under one roof for one week of collaborative discussions and opportunities to expand your network and establish powerful partnerships. What is Access USA?

Pharmacy 40

Pharmacy Gene Therapy Pharma Companies Production 40

pharmaphorum

FEBRUARY 18, 2022

There are more therapies to choose from and different kinds of treatments such as cell and gene therapies that require entirely different engagement models. Additionally, there is complexity in delivery settings, with sites of care changing and services increasingly delivered in communities or via pharmacies.

Gene Therapy 52

Gene Therapy Pharmacy Gene Marketing 52

XTalks

AUGUST 3, 2023

Raphael Pareschi: I started my career in the pharmaceutical industry 16 years ago, transitioning from a background in pharmacy and biochemistry. What are some of the future challenges you see in the approval of novel treatments, including cell and gene therapies?

Regulation 97

Regulation Marketing Life Science Drugs 97

XTalks

JUNE 4, 2024

Today, there’s been a shift towards more complex, large molecules or biologics like monoclonal antibodies, antibody-drug conjugates (ADCs) and advanced therapies like RNA-based treatments and cell and gene therapies. More sophisticated molecules coupled with increasingly complex trial designs “leads to a lot of complexity to deal with.

Clinical Development 110

Clinical Development Development Clinical Trials Clinical Trials 110

pharmaphorum

FEBRUARY 1, 2021

In a nod to issues related to some of the recent breakthroughs in cell and gene therapies – which are hard to manufacture – the agency is also hoping to hear more from companies to reassure them about production and supply too. More has emerged on the new guidelines following the consultation. In 2020 the value was over €1 billion.

Marketing 52

Marketing Medicine Pharmacy Gene Therapy 52

XTalks

OCTOBER 5, 2023

AscellaHealth Based in Berwyn, Pennsylvania, AscellaHealth is a global leader in specialty pharmacy and healthcare services, catering to a wide array of stakeholders, from payers and providers to patients and the life sciences sector.

Pharmacy 52

Pharmacy Life Science Engineer Gene 52

Advarra

JULY 28, 2022

This article explores how these tools work and why biosafety cabinets are preferred in research involving cell and gene therapies. While both pieces of equipment are hoods with directional airflow, they function differently and are intended for different purposes. What is a Biosafety Cabinet? They operate under negative air pressure (i.e.,

Contamination 52

Contamination Biohazard Biohazard Production 52

The Pharma Data

SEPTEMBER 30, 2021

.” To solve those problems, Varadarajan collaborated with Xinli Liu, professor of pharmaceutics at the UH College of Pharmacy, and an expert in nanoparticle delivery. Liu’s team was ready to encapsulate the agonist of the stimulator of interferon genes (STING) within liposomal particles to yield the adjuvant named NanoSTING.

Vaccination 52

Vaccination Vaccine Immune Response Licensing 52

XTalks

NOVEMBER 1, 2024

mL, depending on the pharmacy. Why it sold so well: Zolgensma is a gene therapy classified as personalized or precision medicine, as it is designed to address specific issues arising from an individual’s unique genetic code. mL) is around $620 for a supply of 0.25 Price of Zolgensma: Zolgensma has a price of $2.1

FDA Approval 85

FDA Approval Drugs Botox Sales 85

XTalks

SEPTEMBER 25, 2024

It is caused by mutations in either the NPC1 or NPC2 gene, disrupting the normal transport of cholesterol and other lipids within cells. Zevra said it expects Miplyffa to be available in US pharmacies in the next eight to 12 weeks and is gearing up for launch activities immediately.

Genetics 52

Genetics Drugs Trials Pharmacy 52

XTalks

APRIL 24, 2023

Awareness of rare diseases is growing, and with a better understanding of the pathophysiology of many rare diseases, innovative treatment options are emerging, like gene therapies that can treat the root cause of rare genetic diseases and potentially provide long-term symptom relief, or even a definitive cure.

Gene Therapy 95

Gene Therapy Gene Trials Clinical Trials 95

The Pharma Data

DECEMBER 3, 2020

Hain will focus on key member touchpoints including care management and navigation, provider and value-based care engagement, pharmacy engagement, health risk assessments, social determinant of health management, and other digital health offerings. Prior to GoHealth, Hain served as CMO for Blue Cross and Blue Shield of Texas.

Development 52

Development Business Development Manufacturing Clinical Development 52

Pharmaceutical Technology

DECEMBER 14, 2022

Local UK pharmacies are already reporting and forecasting future shortages of antibiotics to treat Strep A infections. Bacteria naturally develop resistance to antibiotics over time, through genetic mutation, horizontal gene transfer between bacteria, or because of selective pressure. Secondly, antibiotics are not a permanent solution.

Bacteria 130

Bacteria DNA Clinical Trials Clinical Trials 130

Pharmaceutical Technology

JUNE 1, 2023

Strathclyde Institute of Pharmacy and Biomedical Sciences head professor Yvonne Perrie said: “This centre will provide new capabilities for mRNA-based drug development and manufacture of cost-effective vaccines and therapeutics in the UK, boosting not only economic growth but also security of supply.”

Drug Delivery 242

Drug Delivery RNA Development Drugs 242

Drug Channels

OCTOBER 19, 2020

Channel Strategy for First Medical Product – A Look at Channel Considerations for Pharmacy vs. Medical Plus – Tailored Track Options Based on Company Size : Emerging/Small Companies – Infrastructure Set-Up, License Procurement and 3PL Contracting Mid-Large Companies – How Do I Think About My Portfolio Differently Based on Product Type?

Life Science 52

Life Science Pharmacy Gene Therapy Gene 52

Drug Channels

NOVEMBER 8, 2020

Stuart Parker, Senior Director, Trade Relations, Mayne Pharma And more!

Life Science 52

Life Science Pharmacy Gene Therapy Drugs 52

XTalks

MARCH 22, 2023

Just last year, the FDA approved a one-time gene therapy treatment for hemophilia B priced at $3.5 Hemgenix (etranacogene dezaparvovec), developed by CSL Behring, is a gene therapy that allows patients with moderate-to-severe hemophilia to produce their own factor IX, a clotting factor important in controlling bleeding.

Life Science 97

Life Science Drugs FDA Approval Vaccination 97

The Pharma Data

NOVEMBER 20, 2020

Progeria is caused by a point mutation in the LMNA gene, yielding the farnesylated aberrant protein, progerin. Progeroid Laminopathies are genetic conditions of accelerated aging caused by a constellation of mutations in the LMNA and/or Zmpste24 genes yielding farnesylated proteins that are distinct from progerin.

FDA Approval 52

FDA Approval Genetics Clinical Trials Clinical Trials 52

The Pharma Data

JANUARY 16, 2021

” He pledged to ramp up vaccination availability in pharmacies, build mobile clinics to get vaccines to underserved rural and urban communities and encourage states to expand vaccine eligibility to people 65 and older, The New York Times reported. variant that has acquired three gene mutations not previously seen together in the virus.

Vaccination 52

Vaccination Vaccine Nurses Packaging 52